Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on May 26th, 2023%
Results of a small clinical trial show most patients with melanoma receiving a personalized therapeutic vaccine with an approved immunotherapy reduced at least some of their tumors. . . . → Read More: AI-Designed Cancer Vaccine Shown to Act Against Melanoma
By Alan, on May 5th, 2023%
New research with lab animals shows gene-edited viruses can target and remove harmful E. coli bacteria from the gut, including strains usually resistant to antibiotics. . . . → Read More: Crispr Therapy Shown to Remove E. Coli in Gut
By Alan, on May 2nd, 2023%
A genomic analysis of urine samples is shown to predict the most common form of bladder cancer years before symptoms appear. . . . → Read More: DNA Test Detects Early Bladder Cancer in Urine
By Alan, on April 11th, 2023%
A start-up company with a process for harvesting large quantities of cells that infiltrate and kill solid tumors is raising $10 million in seed venture funds. . . . → Read More: Cancer Cell Therapy Biotech Launches, Raises $10M
By Alan, on March 30th, 2023%
A developer of engineered immune cells to treat cancer and immune deficiencies is raising €17.5 million ($US 19.1 million) in equity and grant funding from an EU agency. . . . → Read More: T-Cell Biotech Gains €17.5M in Grant, Equity Funds
By Alan, on March 20th, 2023%
Early results from a clinical trial show a vaccine for the human papillomavirus is safe and invokes immune responses in women with low-grade cervical lesions. . . . → Read More: HPV Vaccine Generates Immune Responses in Trial
By Alan, on March 16th, 2023%
A start-up company developing liquid biopsies for diagnosing cancer by analyzing fluids drained from a patient after surgery is raising $8 million in seed funds. . . . → Read More: Post-Surgical Fluid Cancer Analytics Company Gains $8M
By Alan, on March 9th, 2023%
A new analysis shows machine learning algorithms can provide more diagnostic details in liquid biopsies, blood tests to detect and track solid tumor cancers. . . . → Read More: A.I. Shown to Enhance Diagnostics in Liquid Biopsies
By Alan, on March 7th, 2023%
A clinical trial is underway assessing virtual reality interventions for relieving distress and improve the quality of life for cancer patients receiving bone marrow transplants. . . . → Read More: Trial Testing VR to Relieve Cancer Patient Distress
By Alan, on March 2nd, 2023%
A university lab and biotechnology company are developing new cancer treatments with therapies that stop RNA activity, delivered by advanced nanoscale particles. . . . → Read More: Business-Academic Team to Create RNA Delivery for Cancer
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|